Long-acting Beta-agonists Market - Top Companies and Manufacturers

Companies Dominating the Long-acting Beta-agonists Landscape

C.H. Boehringer Sohn AG & Ko. KG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
GlaxoSmithKline plc
Merck KGaA
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
AstraZeneca plc
Sumitomo Dainippon Pharma Co., Ltd.
Koninklijke Philips N.V.
Pear Therapeutics, Inc.
Sanofi-aventis Groupe

Browse Key Market Insights with Data Illustration:

Long-acting Beta-agonists Market Size, Forecast Report 2036

In the News

October, 2020: Astellas Pharma Inc. and Iota Biosciences, Inc. announced a merger agreement, following which, Astellas will acquire Iota’s unique bioelectronics technology.
December 2019: Boston Biomedical, Inc. announced the alliance in oncology research with Columbia University, Harvard University and The Wistar Institute, the three world-leading oncology centers of excellence.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of long-acting beta-agonists is evaluated at USD 1.1 billion.

Long-acting Beta-agonists Market size was valued at USD 987.4 million in 2023 and is expected to reach USD 5.67 billion by 2036, expanding at around 14.4% CAGR during the forecast period i.e., between 2024-2036. Increasing prevalence of asthma and COPD globally is anticipated to boost the market growth.

Asia Pacific industry is expected to hold largest revenue share by 2036, driven by high prevalence of COPD, bronchospasm, and other disorders amongst the geriatric population.

The major players in the market are GlaxoSmithKline plc, Merck KGaA, Mylan N.V., Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Sumitomo Dainippon Pharma Co., Ltd., Koninklijke Philips N.V., Pear Therapeutics, Inc., and Sanofi-aventis Groupe.

Long-acting Beta-agonists Market - Top Companies and Manufacturers

Companies Dominating the Long-acting Beta-agonists Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the long-acting beta-agonists market worth?

Why is the demand for long-acting beta-agonists growing?

Which region dominated the majority of long-acting beta-agonists industry share?

Who are the top long-acting beta-agonists companies?